Our Pricing

Mounjaro Ingredients List: Active & Inactive Components Explained

Published: 10 September 2026

Understanding the mounjaro ingredients list is essential for patients considering this weight loss treatment, particularly those with allergies or sensitivities to specific pharmaceutical excipients. Mounjaro contains tirzepatide as its active ingredient, alongside carefully selected inactive components that ensure stability, sterility, and effective subcutaneous delivery. This comprehensive breakdown explains every ingredient in the UK-licensed formulation, helping you make informed decisions about your treatment.

Mounjaro Ingredients List: Active Pharmaceutical Ingredient

The primary component in the mounjaro ingredients list is tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Each Mounjaro KwikPen contains tirzepatide in concentrations ranging from 2.5mg to 15mg per 0.5ml injection, depending on the prescribed dose strength. Tirzepatide is a synthetic peptide consisting of 39 amino acids with a C20 fatty diacid moiety, designed to enhance its pharmacokinetic profile and extend its half-life to approximately 5 days, allowing for once-weekly administration [1].

In the SURPASS-1 clinical trial, tirzepatide demonstrated an average weight reduction of up to 15% of body weight at the 15mg dose over 40 weeks, significantly outperforming placebo [2]. The active ingredient works by activating both GIP and GLP-1 receptors, which regulate appetite, food intake, and glucose metabolism. At Cured Pharmacy, Mounjaro containing pharmaceutical-grade tirzepatide is available from £124.99, subject to clinical assessment by our UK-registered prescribers. All treatments are MHRA-licensed and sourced exclusively from UK-licensed wholesalers, ensuring authenticity and regulatory compliance.

Complete Mounjaro Ingredients List: Inactive Excipients

Beyond the active ingredient, the mounjaro ingredients list includes several inactive excipients essential for formulation stability and patient safety. These include sodium chloride (4.1mg per 0.5ml), which maintains isotonicity with body fluids to minimise injection site discomfort; sodium phosphate dibasic heptahydrate (0.7mg), which acts as a buffering agent to maintain pH stability; and disodium phosphate dihydrate, which further supports pH control within the physiological range of 7.0-8.0 [3].

Additionally, water for injections serves as the solvent, ensuring sterility and compatibility with subcutaneous administration. The formulation contains no preservatives, as each KwikPen is designed for single-patient use with pre-measured doses. Patients with known hypersensitivity to any component of the mounjaro ingredients list should inform their prescriber during consultation. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all dispensed medications meet stringent pharmaceutical standards.

Understanding Excipient Function in Mounjaro

Each component in the mounjaro ingredients list serves a specific pharmaceutical purpose. Sodium chloride ensures the solution is isotonic, preventing cellular damage at the injection site. The phosphate buffer system maintains stability during storage and prevents degradation of the tirzepatide molecule. Water for injections meets European Pharmacopoeia standards, guaranteeing sterility and pyrogenicity compliance. This precise formulation has been rigorously tested through Phase 3 trials involving over 10,000 participants across the SURPASS programme [4].

Mounjaro Ingredients List: Allergen and Sensitivity Information

Reviewing the mounjaro ingredients list for potential allergens is crucial for patient safety. Mounjaro does not contain common allergens such as latex, egg proteins, or gelatin. The formulation is free from preservatives like benzyl alcohol or phenol, which can cause sensitivity reactions in some individuals. However, patients with a history of hypersensitivity to tirzepatide or any excipient should not use this medication [5].

During your free online consultation at Cured Pharmacy, our UK-registered prescribers will review your allergy history and assess suitability based on the complete mounjaro ingredients list. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency can use Mounjaro, as it contains none of these sugars. All prescription treatments require clinical assessment to ensure safety and appropriateness for your individual circumstances.

How the Mounjaro Ingredients List Supports Efficacy

The carefully balanced mounjaro ingredients list ensures optimal bioavailability and therapeutic effect. The pH-buffered aqueous solution protects tirzepatide from degradation, maintaining potency throughout the product's shelf life when stored at 2-8°C. The isotonic formulation minimises injection site reactions, with clinical trials reporting injection site reactions in fewer than 3% of participants [6].

The absence of preservatives in the mounjaro ingredients list necessitates proper storage and handling. Each pen should be refrigerated until use, and once removed from refrigeration, it can be kept at room temperature (not exceeding 30°C) for up to 21 days. This formulation strategy ensures that every dose delivers the precise amount of tirzepatide required for consistent appetite suppression and metabolic benefits. At Cured Pharmacy, we provide comprehensive storage instructions with every dispensed treatment, and our clinical team is available on (+44) 116 4646009 for any formulation-related queries.

Pharmaceutical Grade Standards in Mounjaro

Every component in the mounjaro ingredients list meets European Pharmacopoeia standards, ensuring pharmaceutical-grade purity. Tirzepatide is synthesised under Good Manufacturing Practice (GMP) conditions, with batch testing for potency, sterility, and endotoxin levels. The excipients undergo rigorous quality control to prevent contamination or impurities that could compromise patient safety or treatment efficacy.

Comparing Mounjaro Ingredients List to Other Weight Loss Treatments

When examining the mounjaro ingredients list alongside other GLP-1 receptor agonists, key differences emerge in formulation and active ingredients. Wegovy contains semaglutide as its active ingredient, a GLP-1 receptor agonist without GIP activity, formulated with similar excipients including disodium phosphate dihydrate and sodium chloride. Saxenda uses liraglutide, another GLP-1 agonist with a shorter half-life requiring daily administration.

The dual-receptor mechanism of tirzepatide, reflected in the mounjaro ingredients list, distinguishes it from single-pathway treatments. In head-to-head trials, tirzepatide demonstrated superior weight loss compared to semaglutide, with an average additional 5kg reduction at comparable timeframes [7]. Understanding these compositional differences helps patients and prescribers select the most appropriate treatment. All weight loss medications at Cured Pharmacy require clinical assessment and are dispensed only following prescriber approval.

Mounjaro Ingredients List: Storage and Stability Considerations

The mounjaro ingredients list is optimised for stability under refrigerated conditions, with tirzepatide remaining chemically stable for up to 24 months when stored at 2-8°C. The phosphate buffer system prevents pH drift that could denature the peptide structure, while the absence of preservatives eliminates long-term toxicity concerns associated with repeated exposure to antimicrobial agents [8].

Once in use, the mounjaro ingredients list remains stable at room temperature for up to 21 days, providing flexibility for patients who travel or have limited refrigeration access. The KwikPen design protects the formulation from light exposure, which could degrade tirzepatide. Patients should never freeze Mounjaro, as ice crystal formation can disrupt the molecular structure of the active ingredient and excipients. At Cured Pharmacy, we provide temperature-controlled shipping to ensure your medication arrives in optimal condition, and our pharmacists offer personalised storage guidance to maintain treatment efficacy throughout your weight loss programme.

Expiry and Disposal of Mounjaro

Understanding the mounjaro ingredients list helps explain proper disposal procedures. Used pens should be disposed of in sharps containers to prevent needlestick injuries and environmental contamination. The pharmaceutical ingredients, including tirzepatide and excipients, should not enter water systems. Cured Pharmacy provides disposal guidance with every order, and patients can return used pens to any UK pharmacy for safe pharmaceutical waste management.

Scientific References

1. Frias, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 10 September 2026]
2. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 10 September 2026]
3. Electronic Medicines Compendium. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. [accessed 10 September 2026]
4. Dahl, D., et al. (2022). Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes: The SURPASS-5 randomized clinical trial. JAMA, 327(6), 534-545. [accessed 10 September 2026]
5. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro (tirzepatide): Product information and safety updates. GOV.UK. [accessed 10 September 2026]
6. Ludvik, B., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. [accessed 10 September 2026]
7. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
8. European Pharmacopoeia Commission. (2023). Tirzepatide monograph. European Pharmacopoeia 11th Edition. [accessed 10 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.